Cover Image

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

Show other versions (1)

Drotrecogin alfa (activated) is approved for use in patients with sepsis who are at high risk for death. This controlled trial found no benefit in patients at a low risk for death (relative risk of death with drotrecogin alfa, 1.08). The rate of serious bleeding was higher with drotrecogin alfa. Dro...

Full description

Saved in:
Bibliographic Details
Main Authors: Abraham, Edward P. (Author) , Laterre, Pierre-François (Author) , Garg, Rekha (Author) , Levy, Howard (Author) , Talwar, Deepak (Author) , Trzaskoma, Benjamin L. (Author) , François, Bruno (Author) , Guy, Jeffrey S. (Author) , Brückmann, Martina (Author) , Rea-Neto, Álvaro (Author) , Rossaint, Rolf (Author) , Perrotin, Dominique (Author) , Sablotzki, Armin (Author) , Arkins, Nancy (Author) , Utterback, Barbara G. (Author) , Macias, William L. (Author)
Format: Article (Journal)
Language:English
Published: September 29, 2005
In: The New England journal of medicine
Year: 2005, Volume: 353, Issue: 13, Pages: 1332-1341
ISSN:1533-4406
DOI:10.1056/NEJMoa050935
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa050935
Get full text
Author Notes:Edward Abraham, M.D., Pierre-François Laterre, M.D., Rekha Garg, M.D., Howard Levy, M.D., Ph.D., Deepak Talwar, M.D., Benjamin L. Trzaskoma, M.S., Bruno François, M.D., Jeffrey S. Guy, M.D., Martina Brückmann, M.D., Álvaro Rea-Neto, M.D., Rolf Rossaint, M.D., Dominique Perrotin, M.D., Armin Sablotzki, M.D., Ph.D., Nancy Arkins, R.N., Barbara G. Utterback, M.S., M.B.A., and William L. Macias, M.D., for the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 1800520050
003 DE-627
005 20220820172723.0
007 cr uuu---uuuuu
008 220428s2005 xx |||||o 00| ||eng c
024 7 |a 10.1056/NEJMoa050935  |2 doi 
035 |a (DE-627)1800520050 
035 |a (DE-599)KXP1800520050 
035 |a (OCoLC)1341459288 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Abraham, Edward P.  |d 1913-1999  |e VerfasserIn  |0 (DE-588)12836369X  |0 (DE-627)384615287  |0 (DE-576)181512203  |4 aut 
245 1 0 |a Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death  |c Edward Abraham, M.D., Pierre-François Laterre, M.D., Rekha Garg, M.D., Howard Levy, M.D., Ph.D., Deepak Talwar, M.D., Benjamin L. Trzaskoma, M.S., Bruno François, M.D., Jeffrey S. Guy, M.D., Martina Brückmann, M.D., Álvaro Rea-Neto, M.D., Rolf Rossaint, M.D., Dominique Perrotin, M.D., Armin Sablotzki, M.D., Ph.D., Nancy Arkins, R.N., Barbara G. Utterback, M.S., M.B.A., and William L. Macias, M.D., for the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group 
264 1 |c September 29, 2005 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.04.2022 
520 |a Drotrecogin alfa (activated) is approved for use in patients with sepsis who are at high risk for death. This controlled trial found no benefit in patients at a low risk for death (relative risk of death with drotrecogin alfa, 1.08). The rate of serious bleeding was higher with drotrecogin alfa. Drotrecogin alfa should not be used in patients with sepsis who have a low risk of death, such as those with single-organ failure or an APACHE II score below 25. 
700 1 |a Laterre, Pierre-François  |e VerfasserIn  |4 aut 
700 1 |a Garg, Rekha  |e VerfasserIn  |4 aut 
700 1 |a Levy, Howard  |e VerfasserIn  |4 aut 
700 1 |a Talwar, Deepak  |e VerfasserIn  |4 aut 
700 1 |a Trzaskoma, Benjamin L.  |e VerfasserIn  |4 aut 
700 1 |a François, Bruno  |e VerfasserIn  |4 aut 
700 1 |a Guy, Jeffrey S.  |e VerfasserIn  |4 aut 
700 1 |a Brückmann, Martina  |d 1970-  |e VerfasserIn  |0 (DE-588)121145069  |0 (DE-627)705257290  |0 (DE-576)292557736  |4 aut 
700 1 |a Rea-Neto, Álvaro  |e VerfasserIn  |4 aut 
700 1 |a Rossaint, Rolf  |e VerfasserIn  |4 aut 
700 1 |a Perrotin, Dominique  |e VerfasserIn  |4 aut 
700 1 |a Sablotzki, Armin  |e VerfasserIn  |4 aut 
700 1 |a Arkins, Nancy  |e VerfasserIn  |4 aut 
700 1 |a Utterback, Barbara G.  |e VerfasserIn  |4 aut 
700 1 |a Macias, William L.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The New England journal of medicine  |d Waltham, Mass. : MMS, 1928  |g 353(2005), 13, Seite 1332-1341  |h Online-Ressource  |w (DE-627)266889484  |w (DE-600)1468837-2  |w (DE-576)075962454  |x 1533-4406  |7 nnas  |a Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death 
773 1 8 |g volume:353  |g year:2005  |g number:13  |g pages:1332-1341  |g extent:10  |a Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |t Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death  |d 2005  |w (DE-627)509214789  |w (DE-576)9509214787 
856 4 0 |u https://doi.org/10.1056/NEJMoa050935  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220428 
993 |a Article 
994 |a 2005 
998 |g 121145069  |a Brückmann, Martina  |m 121145069:Brückmann, Martina  |d 60000  |d 61000  |e 60000PB121145069  |e 61000PB121145069  |k 0/60000/  |k 1/60000/61000/  |p 9 
999 |a KXP-PPN1800520050  |e 4125406219 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2005","dateIssuedDisp":"September 29, 2005"}],"name":{"displayForm":["Edward Abraham, M.D., Pierre-François Laterre, M.D., Rekha Garg, M.D., Howard Levy, M.D., Ph.D., Deepak Talwar, M.D., Benjamin L. Trzaskoma, M.S., Bruno François, M.D., Jeffrey S. Guy, M.D., Martina Brückmann, M.D., Álvaro Rea-Neto, M.D., Rolf Rossaint, M.D., Dominique Perrotin, M.D., Armin Sablotzki, M.D., Ph.D., Nancy Arkins, R.N., Barbara G. Utterback, M.S., M.B.A., and William L. Macias, M.D., for the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["266889484"],"issn":["1533-4406"],"zdb":["1468837-2"]},"language":["eng"],"titleAlt":[{"title":"NEJM"}],"recId":"266889484","title":[{"title_sort":"New England journal of medicine","subtitle":"NEJM","title":"The New England journal of medicine"}],"note":["Gesehen am 04.08.25"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["198.1928 -"],"disp":"Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of deathThe New England journal of medicine","origin":[{"publisher":"MMS ; MMS","dateIssuedDisp":"1928-","dateIssuedKey":"1928","publisherPlace":"Waltham, Mass. ; Boston, Mass."}],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"Massachusetts Medical Society"}],"name":{"displayForm":["Massachusetts Medical Society"]},"part":{"volume":"353","pages":"1332-1341","year":"2005","issue":"13","extent":"10","text":"353(2005), 13, Seite 1332-1341"}}],"id":{"doi":["10.1056/NEJMoa050935"],"eki":["1800520050"]},"language":["eng"],"physDesc":[{"extent":"10 S."}],"recId":"1800520050","note":["Gesehen am 28.04.2022"],"person":[{"given":"Edward P.","role":"aut","roleDisplay":"VerfasserIn","family":"Abraham","display":"Abraham, Edward P."},{"roleDisplay":"VerfasserIn","family":"Laterre","display":"Laterre, Pierre-François","role":"aut","given":"Pierre-François"},{"given":"Rekha","role":"aut","display":"Garg, Rekha","family":"Garg","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Howard","roleDisplay":"VerfasserIn","display":"Levy, Howard","family":"Levy"},{"family":"Talwar","display":"Talwar, Deepak","roleDisplay":"VerfasserIn","given":"Deepak","role":"aut"},{"role":"aut","given":"Benjamin L.","display":"Trzaskoma, Benjamin L.","family":"Trzaskoma","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"François, Bruno","family":"François","given":"Bruno","role":"aut"},{"display":"Guy, Jeffrey S.","family":"Guy","roleDisplay":"VerfasserIn","role":"aut","given":"Jeffrey S."},{"roleDisplay":"VerfasserIn","display":"Brückmann, Martina","family":"Brückmann","given":"Martina","role":"aut"},{"family":"Rea-Neto","display":"Rea-Neto, Álvaro","roleDisplay":"VerfasserIn","given":"Álvaro","role":"aut"},{"role":"aut","given":"Rolf","display":"Rossaint, Rolf","family":"Rossaint","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Dominique","roleDisplay":"VerfasserIn","display":"Perrotin, Dominique","family":"Perrotin"},{"roleDisplay":"VerfasserIn","display":"Sablotzki, Armin","family":"Sablotzki","given":"Armin","role":"aut"},{"family":"Arkins","display":"Arkins, Nancy","roleDisplay":"VerfasserIn","given":"Nancy","role":"aut"},{"family":"Utterback","display":"Utterback, Barbara G.","roleDisplay":"VerfasserIn","given":"Barbara G.","role":"aut"},{"role":"aut","given":"William L.","roleDisplay":"VerfasserIn","display":"Macias, William L.","family":"Macias"}],"title":[{"title_sort":"Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death","title":"Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a ABRAHAMEDWDROTRECOGI2920 

Similar Items